About Chiesi Group Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative ...
In India, we are quick to visit a doctor for fever, stomach pain, or a bad cough. But when it comes to the eyes, most people ...
YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...
TAIPEI (Taiwan News) — Taiwan confirmed its first hantavirus-related death of the year on Friday, involving a man in his 70s who lived in Taipei. He died on Jan. 13, about eight days after developing ...
The FDA granted fast track designation to IBI3003 for patients with relapsed/refractory multiple myeloma after receiving four-plus lines of therapy.
The cardiovascular benefits of the hot rooms are backed by data, but new research is looking at whether heat can shield the ...
DARZALEX FASPRO ® U.S. Prescribing Information. 2 Johnson & Johnson Innovative Medicine. DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet ...
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for ...
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for ...
Akron Children’s is among the first U.S. hospitals using a new drug to prevent amputations among frostbite victims.
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results